This is the authors' abstract. We don't add key points for this paper.
The National Institute for Health and Care Excellence (NICE) guidelines for the management of irritable bowel syndrome (IBS) state that invasive tests, such as colonoscopy, are not required to make a diagnosis of IBS.1 However, in a recent survey conducted among GPs, approximately 70% believed that IBS was a diagnosis of exclusion,2 although whether this meant that they felt invasive investigations were required to reach a diagnosis of IBS was not examined. Nevertheless, this finding is supported by other studies and is important, as clinicians who consider IBS to be a diagnosis of exclusion are more likely to request invasive tests, and to refer patients on to secondary care, resulting in increased healthcare costs.3 One potential reason for the reluctance of GPs to adopt a positive approach to diagnosing IBS may be due to concerns of a missed organic pathology in individuals with a change in bowel habit, particularly colorectal cancer. However, in the absence of alarm features, this diagnosis is uncommon, reported as only 1% in patients with symptoms compatible with a diagnosis of IBS.4 Another possible explanation is that the symptom-based criteria used to diagnose IBS are unwieldy, and are therefore not used routinely in primary care.2 In addition, such symptom-based criteria perform only modestly in differentiating IBS from organic disease, with a meta-analysis reporting sensitivities of between 42% and 90%, and specificities …
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sood et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: